GTXI - GTX Incorporated

Your Recent Quotes: 0 | 0

GTX Incorporated

TRADE NOW Related Information and Financials
Price Glossary Definition
14.03 -0.12
-0.85%
11/21/08 4:00
Open
14.39
Prev Close
14.15
Volume
220,057
52 Wk. Range
10.75- 20.20
Year-to-Date Performance Glossary Definition
DOWN -2.23%
Latest Dividend
Dividend
N/A
Yield
0.00
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
-9.96
 
0.00
 
12.60
GTXI
Sect. Av.
S&P 500
Market Cap
514,578,900
Outstanding Shares
36,236,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy GTXI Rating Report
Target Price (1Yr)
High
31.00
Revenue
19,000,000

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
-5.00
2.82
0.56
Net Income
N/A
0.81
0.00
EPS
N/A
3.64
0.00

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-20.33
-0.57
76.70
Earnings Per Share($)

12/2005
 
 
 
-1.42
12/2006
 
 
 
-1.14
12/2007
 
 
 
-1.16

Earnings
EBITDA
-50,404,000
Revenue
7,126,000
Outside Analyst Rating History

11/22/08
2
Buy
11/22/08
3
Hold
11/22/08
0
Sell

Jim Cramer Portfolio
Find out now if GTXI is in Jim's personal portfolio at Action Alerts PLUS.

Price & Volume

Compare This Stock
Latest Headlines
GTX Inc. tacks on 4.88% on positive news about its muscle drug Ostarine, while preliminary earnings results send Affymetrix shares down 22%.

3:22PM 10/13/08

Xoma's promising study results on a diabetes drug makes it more likely it will find a partner.

3:14PM 09/12/08

Vivus climbs on interim data for a midstage study on obesity drug Qnexa.

6:22PM 05/23/08

Cramer says the company is well positioned to profit on the rapid growth of wind power.

7:48PM 05/14/08

The biotech rises on a narrowed first-quarter loss.

6:00PM 05/12/08

The crew likes the wrestling promoter's stock.

7:09PM 02/25/08

Shares vault 36% after Acapodene shows success in reducing prostate cancer treatment side effects.

4:22PM 02/25/08

Genentech's new Avastin approval helps lift the biotech sector.

3:35PM 02/25/08

Myriad Genetics and Dendreon are among those with major clinical trials next year.

12:06PM 12/12/07

Sigma Designs and GTX trade lower on negative analyst research.

10:04PM 05/02/07

Understanding the Market

Our Experts' Take at RealMoney
However, option traders boost January calls.

4:37PM 11/21/08

This market is producing a few stocks that could represent exceptional opportunities.

3:03PM 11/21/08

More Experts' Takes


Premium Stock Ideas
Is Cramer trading GTXI in his Action Alerts Plus Portfolio?

Premium Services